Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000253445 | SCV000302516 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001705330 | SCV000524801 | likely benign | not provided | 2021-06-14 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24951259) |
Invitae | RCV000473343 | SCV000560627 | likely benign | Fanconi anemia | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988204 | SCV001137841 | likely benign | Fanconi anemia complementation group A | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001010048 | SCV001170191 | likely benign | Hereditary cancer-predisposing syndrome | 2019-05-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV003316340 | SCV004017621 | likely benign | Fanconi anemia complementation group C | 2023-07-07 | criteria provided, single submitter | clinical testing |